Hebb, a neurosurgery professor at Western University’s Schulich School of Medicine & Dentistry, took tumor samples removed during surgery back to his laboratory, implanted electrodes and stimulated the cancer cells. The tumors responded.

That unexpected observation set in motion years of research into what is now called Intratumoral Modulation Therapy, or IMT—an original approach that uses low-amplitude electric fields to disrupt the growth of glioblastoma, one of the most aggressive and difficult-to-treat brain cancers.